Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Nasopharyngeal Carcinoma · Recurrent Nasopharyngeal Carcinoma · Stage IV Nasopharyngeal Carcinoma AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Kaiser Permanente Dublin, Dublin, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente Fresno Orchard Plaza, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · 833-574-2273
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Fresno, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 213-388-0908
    Contact: Principal Investigator (Jacob S. Thomas)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Jacob S. Thomas)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Jacob S. Thomas)
  • Kaiser Permanente- Modesto MOB II, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Modesto, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Jacob S. Thomas)
  • Kaiser Permanente-Oakland, Oakland, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · ccto-office@stanford.edu · 650-498-7061
    Contact: Principal Investigator (Alexander D. Colevas)
  • Kaiser Permanente-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente Downtown Commons, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Siao-Yi Wang)
  • Kaiser Permanente-South Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente San Leandro, San Leandro, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser San Rafael-Gallinas, San Rafael, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-South San Francisco, South San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Vallejo, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Jed A. Katzel)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Conor E. Steuer)
  • Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · shelley.a.clark@kp.org · 808-432-5195
    Contact: Principal Investigator (Jed A. Katzel)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Jochen H. Lorch)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Ameen Salahudeen)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (Jochen H. Lorch)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Jochen H. Lorch)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Prem Sobti)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Saint Anthony Regional Hospital, Carroll, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · sbenson@iora.org · 515-689-7658
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States

  • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · kathryn.bartz@nmhs.org · 402-354-7939
    Contact: Principal Investigator (Yungpo B. Su)
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ, Council Bluffs, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · Liza.brandes@nmhs.org · 402-354-5892
    Contact: Principal Investigator (Yungpo B. Su)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-334-4773
    Contact: Principal Investigator (Yungpo B. Su)
  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Yungpo B. Su)
  • Oncology Associates PC, Omaha, Nebraska, United States

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States

  • University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States

  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Minh Phan)
  • Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States

  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (John M. Kaczmar)
  • Swedish Medical Center-First Hill, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Dan S. Zuckerman)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Contact: Study coordinator (Site Public Contact) · 61 3 9656 1521
    Contact: Principal Investigator (Danny Rischin)
  • University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · clinical.trials@uhn.on.ca · 416-946-4501
    Contact: Principal Investigator (Enrique Sanz Garcia)
  • Chinese University of Hong Kong-Prince of Wales Hospital, Shatin, Hong Kong

    Contact: Study coordinator (Site Public Contact) · ccrb@cuhk.edu.hk
    Contact: Principal Investigator (Brigette B. Ma)
  • National University Hospital Singapore, Singapore, Singapore

    Contact: Study coordinator (Site Public Contact) · horg@nuhs.edu.sg
    Contact: Principal Investigator (Boon C. Goh)
  • National Cancer Centre Singapore, Singapore, Singapore

    Contact: Study coordinator (Site Public Contact) · cancerhelpline@nccs.com.sg · 65 6225 5655
    Contact: Principal Investigator (Wan Teck D. Lim)
Study leads
  • Brigette B Ma

    Principal Investigator

    NRG Oncology